Lifescience Logistics Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Lifescience Logistics Pharmaceutical Import Records from India — 5 Products, $19.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Lifescience Logistics — Pharmaceutical Importer Profile (2026) | 5 Products, $19.1M Trade | TransData Nexus

Lifescience Logistics

Pharmaceutical Importer · United States · Cardiovascular Focus · $19.1M Total Trade · DGFT Verified

Lifescience Logistics is a pharmaceutical importer based in United States with a total trade value of $19.1M across 5 products in 4 therapeutic categories. Based on 402 verified import shipments from Indian Customs (DGFT) records, Lifescience Logistics is the #1 buyer in 2 products including Celecoxib, Verapamil. Lifescience Logistics sources from 6 verified Indian suppliers, with Umedica Laboratories Private Limited accounting for 66.6% of imports.

Lifescience Logistics — Import Portfolio & Supplier Network

Lifescience Logistics import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Lifescience Logistics?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Umedica Laboratories Private Limited	$11.5M	409	66.6%
Cadila Pharmaceuticals Limited	$5.4M	181	31.3%
Cohance Lifesciences Limited

What Formulations Does Lifescience Logistics Import?

Formulation	Value	Ships
Carbamazepine tablets USP 200MG (Each	$912.3K	24
Pharmaceuticals medicines: verapamil	$700.0K	14
Celecoxib capsules 200MG [Pack of 500	$311.0K	10
Atorvastatin calcium tablets USP 40MG [Pack of 1000	$302.0K	11
Carbamazepine tablets USP 200MG Each	$299.1K	10
Sildenafil tablets USP 100MG (Pack of	$275.7K	7
Atorvastatin calcium tablets USP 40MG	$260.6K	6
Atorvastatin calcium tablets USP 20MG [Pack of 1000	$223.6K	7
Atorvastatin calcium tablets USP 80MG	$220.0K	6
Pharmaceuticals medicines	$219.8K	7
Carbamazepine tablets USP 200MG (Pack of100 tablets)	$213.3K	12
Atorvastatin calcium tablets USP 20MG	$203.8K	6
Atorvastatin calcium tablets USP	$200.0K	4
Sildenafil tablets USP 100MG (Pack of 1000 tablets)	$196.4K	5
Carbamazepine tablets USP 200MG [Pack of100	$186.5K	12

Lifescience Logistics imports 254 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Atorvastatin	Cardiovascular	$6.7M	133	0.6%	5
2	Calcium	Vitamins & Supplements	$5.8M	117	0.7%	6
3	Celecoxib	Analgesics & Antipyretics	$3.0M	59	2.2%	1
4	Verapamil	Cardiovascular	$2.6M	53	0.7%	1
5	Erythromycin	Antibiotics	$989.1K	40	1.2%	8

Lifescience Logistics imports 5 pharmaceutical products across 4 categories into United States totaling $19.1M. The company is the #1 buyer for 2 products: Celecoxib, Verapamil.

Lifescience Logistics — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Lifescience Logistics is a U.S.-based pharmaceutical importer specializing in the acquisition of finished pharmaceutical formulations from India. Operating as a buyer, the company plays a pivotal role in sourcing and importing a diverse range of pharmaceutical products to meet the demands of the U.S. market. Headquartered in the United States, Lifescience Logistics collaborates with various Indian pharmaceutical manufacturers to ensure a steady supply of medications across multiple therapeutic categories.

In the United States pharmaceutical distribution landscape, Lifescience Logistics functions as a key intermediary, facilitating the entry of foreign-manufactured drugs into the domestic market. By importing finished formulations, the company contributes to the availability of a wide array of pharmaceutical products, thereby enhancing the diversity and accessibility of medications for healthcare providers and patients nationwide.

2Distribution Network

While specific details about Lifescience Logistics' warehouse locations and logistics capabilities are not publicly disclosed, the company is known to operate a distribution network within the United States. This network is designed to efficiently handle the storage and distribution of pharmaceutical products, ensuring timely delivery to various stakeholders in the healthcare sector. The logistics infrastructure is tailored to meet the stringent requirements of pharmaceutical distribution, including temperature control and regulatory compliance.

3Industry Role

Lifescience Logistics serves as a pharmaceutical importer, sourcing finished pharmaceutical formulations from Indian manufacturers and facilitating their entry into the U.S. market. By acting as an intermediary between foreign manufacturers and domestic healthcare providers, the company plays a crucial role in diversifying the pharmaceutical supply chain and enhancing the availability of medications. This position allows Lifescience Logistics to influence market dynamics by introducing a variety of products, potentially impacting pricing and competition within the U.S. pharmaceutical sector.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Lifescience Logistics

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Lifescience Logistics demonstrates a high degree of sourcing concentration, with a significant portion of its imports originating from a single supplier, Umedica Laboratories Private Limited. This supplier accounts for approximately 66.6% of the total import value, indicating a strong reliance on this manufacturer. Such concentration can present risks, including potential supply chain disruptions if issues arise with the primary supplier. However, the company's extensive number of shipments (409) from Umedica suggests a stable and ongoing relationship, which may mitigate some of these risks. The remaining imports are distributed among other suppliers, with Cadila Pharmaceuticals Limited contributing 31.3% and smaller contributions from other manufacturers.

2Supply Chain Resilience

The resilience of Lifescience Logistics' supply chain is closely tied to its sourcing strategy. The heavy reliance on Umedica Laboratories Private Limited for the majority of imports indicates a potential vulnerability to supply chain disruptions. While the company imports a diverse range of formulations (254 unique products), the concentration of sourcing from a single supplier may limit its ability to quickly adapt to changes or challenges within that supplier's operations. Additionally, the exposure to specific shipping routes and the regulatory compliance status of the primary supplier are critical factors influencing the overall resilience of the supply chain.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth the legal framework for drug imports, ensuring that all imported drugs meet the standards for quality, safety, and effectiveness. The FDA's regulations require that imported drugs be manufactured in compliance with quality requirements, appropriately labeled, and approved for sale in the U.S. market. Additionally, the FDA reviews shipments of imported drugs to determine their admissibility into the U.S., and drugs that do not meet FDA standards may be refused entry.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are governed by the FDA. Importers must ensure that their products comply with FDA regulations, including obtaining necessary approvals and certifications. Good Manufacturing Practice (GMP) certification is a critical component of this compliance. The FDA recognizes GMP certifications from various international standards, including EU GMP, WHO GMP, and PIC/S. Importers must verify that their suppliers hold valid GMP certifications to ensure the quality and safety of the imported pharmaceutical products. Additionally, wholesale distribution authorization is required for entities involved in the distribution of pharmaceutical products within the U.S. market.

Lifescience Logistics — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Lifescience Logistics focuses on importing pharmaceutical products across three primary therapeutic categories: cardiovascular, vitamins & supplements, and analgesics & antipyretics. This strategic focus aligns with market demand for essential medications in these areas. The company's top five imported products—Celecoxib, Verapamil, Atorvastatin, Calcium, and Erythromycin—are commonly prescribed for conditions such as hypertension, cholesterol management, pain relief, and bacterial infections. By concentrating on these therapeutic areas, Lifescience Logistics aims to meet the critical healthcare needs of the U.S. population, ensuring the availability of vital medications.

2Sourcing Profile

Lifescience Logistics employs a sourcing strategy that emphasizes importing finished pharmaceutical formulations from Indian manufacturers. This approach allows the company to leverage India's robust pharmaceutical manufacturing capabilities, which are known for producing high-quality generics at competitive prices. The focus on finished formulations enables Lifescience Logistics to offer a diverse product portfolio without the complexities associated with raw material sourcing or manufacturing. India's compliance with international GMP standards further supports the company's sourcing strategy, ensuring that imported products meet the stringent quality requirements of the U.S. market.

Market Positioning

Seller's Guide — How to Become a Supplier to Lifescience Logistics

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Lifescience Logistics, particularly if they can offer products that complement the company's existing portfolio. Potential gaps in Lifescience Logistics's current sourcing include specific formulations or dosage forms not currently imported. Indian exporters can explore these opportunities by ensuring their products meet FDA regulatory requirements, possess valid GMP certifications, and align with the therapeutic areas of interest to Lifescience Logistics. Establishing a reliable supply chain and demonstrating consistent product quality will be crucial for new suppliers seeking to enter this market segment.

2Requirements & Qualifications

Indian exporters aiming to supply Lifescience Logistics and the broader U.S. market must adhere to several key requirements. Products must be manufactured in compliance with recognized GMP standards, such as EU GMP, WHO GMP, or PIC/S. Exporters must obtain necessary import licenses and ensure that their products meet FDA labeling and packaging regulations, including providing accurate and truthful information in English. Additionally, products must pass FDA inspections and be approved for sale in the U.S. market. Maintaining a robust quality management system and staying informed about regulatory changes are essential for ongoing compliance.

Frequently Asked Questions — Lifescience Logistics

What products does Lifescience Logistics import from India?

Lifescience Logistics imports 5 pharmaceutical products across 4 categories. Top imports: Atorvastatin ($6.7M), Calcium ($5.8M), Celecoxib ($3.0M), Verapamil ($2.6M), Erythromycin ($989.1K).

Who supplies pharmaceuticals to Lifescience Logistics from India?

Lifescience Logistics sources from 6 verified Indian suppliers. The primary supplier is Umedica Laboratories Private Limited (66.6% of imports, $11.5M).

What is Lifescience Logistics's total pharmaceutical import value?

Lifescience Logistics's total pharmaceutical import value from India is $19.1M, based on 402 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Lifescience Logistics focus on?

Lifescience Logistics imports across 4 categories. The largest: Cardiovascular (48.7%), Vitamins & Supplements (30.6%), Analgesics & Antipyretics (15.5%).

Get Full Lifescience Logistics Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.